Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Healthcare Sector Analysis

UpdatedJun 13, 2026
DataAggregated Company Financials
Companies120
  • 7D-3.7%
  • 3M7.9%
  • 1Y32.0%
  • YTD2.7%

Over the last 7 days, the Healthcare industry has dropped 1.4%, driven by Curaleaf Holdings declining 15%. On the other hand kneat.com is actually up 19%. Over the past 12 months, the industry was up 32%. As for the next few years, earnings are expected to grow by 30% per annum.

Sector Valuation and Performance

Has the Canadian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 13 Jun 2026CA$33.6bCA$17.2b-CA$2,022,812,118.1117.6x-16.6x2x
Mon, 11 May 2026CA$37.2bCA$17.8b-CA$1,565,504,581.4425.8x-23.8x2.1x
Wed, 08 Apr 2026CA$32.9bCA$17.5b-CA$1,910,497,854.9718.4x-17.2x1.9x
Fri, 06 Mar 2026CA$33.4bCA$17.7b-CA$2,034,223,428.0617.2x-16.4x1.9x
Sun, 01 Feb 2026CA$31.9bCA$17.5b-CA$2,215,103,317.7622.6x-14.4x1.8x
Tue, 30 Dec 2025CA$34.9bCA$19.2b-CA$2,207,938,156.6319.6x-15.8x1.8x
Thu, 27 Nov 2025CA$31.7bCA$19.4b-CA$2,177,433,265.1718.3x-14.6x1.6x
Sat, 25 Oct 2025CA$37.4bCA$19.5b-CA$2,327,169,845.7442.7x-16.1x1.9x
Mon, 22 Sep 2025CA$35.0bCA$19.4b-CA$2,302,508,604.7440.8x-15.2x1.8x
Wed, 20 Aug 2025CA$35.0bCA$20.0b-CA$2,844,518,829.3836.1x-12.3x1.7x
Fri, 18 Jul 2025CA$28.2bCA$19.6b-CA$2,800,129,289.9023.6x-10.1x1.4x
Sun, 15 Jun 2025CA$27.1bCA$19.4b-CA$2,769,732,386.2922.1x-9.8x1.4x
Tue, 13 May 2025CA$27.6bCA$19.7b-CA$2,772,763,024.6526x-10x1.4x
Thu, 10 Apr 2025CA$23.6bCA$19.8b-CA$2,816,540,681.1121.8x-8.4x1.2x
Sat, 08 Mar 2025CA$27.0bCA$20.1b-CA$2,886,381,150.2523.6x-9.4x1.3x
Mon, 03 Feb 2025CA$28.0bCA$19.9b-CA$2,686,213,142.7027.4x-10.4x1.4x
Wed, 01 Jan 2025CA$28.2bCA$19.8b-CA$2,729,524,680.2430.6x-10.3x1.4x
Fri, 29 Nov 2024CA$30.5bCA$19.8b-CA$2,831,306,535.7720.3x-10.8x1.5x
Sun, 27 Oct 2024CA$35.6bCA$19.5b-CA$2,987,756,861.1020.7x-11.9x1.8x
Tue, 24 Sep 2024CA$32.2bCA$19.3b-CA$2,973,143,203.8721.4x-10.8x1.7x
Thu, 22 Aug 2024CA$32.6bCA$19.2b-CA$3,014,027,453.3521.9x-10.8x1.7x
Sat, 20 Jul 2024CA$33.9bCA$19.2b-CA$3,664,487,995.6919.5x-9.3x1.8x
Mon, 17 Jun 2024CA$32.2bCA$19.3b-CA$3,314,130,015.5017.1x-9.7x1.7x
Wed, 15 May 2024CA$36.7bCA$19.4b-CA$3,927,908,870.7115.8x-9.4x1.9x
Fri, 12 Apr 2024CA$37.2bCA$19.5b-CA$4,081,487,929.8813.3x-9.1x1.9x
Sun, 10 Mar 2024CA$31.8bCA$19.3b-CA$4,472,419,242.5315.4x-7.1x1.6x
Tue, 06 Feb 2024CA$34.9bCA$19.2b-CA$6,460,767,120.2615.8x-5.4x1.8x
Thu, 04 Jan 2024CA$33.8bCA$20.0b-CA$7,656,169,419.0010.6x-4.4x1.7x
Sat, 02 Dec 2023CA$32.8bCA$20.1b-CA$7,707,648,595.0015.6x-4.3x1.6x
Mon, 30 Oct 2023CA$29.0bCA$20.1b-CA$8,447,091,543.0017.2x-3.4x1.4x
Wed, 27 Sep 2023CA$35.5bCA$20.5b-CA$8,954,418,075.0017.5x-4x1.7x
Fri, 25 Aug 2023CA$29.0bCA$20.6b-CA$9,108,543,407.0018.4x-3.2x1.4x
Sun, 23 Jul 2023CA$30.8bCA$20.5b-CA$10,784,552,262.0021.1x-2.9x1.5x
Tue, 20 Jun 2023CA$30.1bCA$20.6b-CA$10,501,373,548.0018.4x-2.9x1.5x
Price to Earnings Ratio

-2.9x


Total Market Cap: CA$30.1bTotal Earnings: -CA$10,501,373,548.00Total Revenue: CA$20.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Healthcare Sector Price to Earnings3Y Average -10.2x202420252026
Current Industry PE
  • Investors are optimistic on the Canadian Healthcare industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 1.7x is lower than the industry's current PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 5.9% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare sector?

CA Market1.43%
Healthcare-3.70%
Healthtech2.53%
Life Sciences-1.45%
Medical Equipment-2.01%
Healthcare Services-2.74%
Biotech-4.16%
Pharma-5.36%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 9.4x.
    • Analysts are expecting annual earnings growth of 52.8%, which is higher than its past year's earnings decline of 11.9% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 90% over the next 5 years.
  • However this is lower than its past earnings growth rate of 157% per year.
  • In contrast, the Biotech industry is expected to see its earnings decline by 11% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
KSI kneat.comCA$6.4418.8%
+CA$98.1m		-2.7%PS9.3x
GUD Knight TherapeuticsCA$9.4810.1%
+CA$85.4m		57.2%PE165.9x
VRNO Verano HoldingsCA$8.504.3%
+CA$25.5m		161.5%PS0.5x
HBFG Happy Belly Food GroupCA$1.657.8%
+CA$18.0m		47.3%PS10x
AIDR Rocket Doctor AICA$0.7126.8%
+CA$14.5m		86.8%n/a

Latest News

NVRS
CA$2.00
Noveris Health Sciences
7D
-30.1%
1Y
700.0%
GTII
CA$11.18
Green Thumb Industries
7D
-2.8%
1Y
66.6%
Narrative Update • Jun 11

GTII: Rescheduling Order And Buybacks Will Support Higher Future Share Price

Analysts have increased their CA$ fair value estimate for Green Thumb Industries from CA$18.08 to CA$20.31, citing higher price targets and optimism around recent regulatory developments, including views that partial cannabis rescheduling could be extremely favorable for the sector. Analyst Commentary Bullish Takeaways Bullish analysts point to the higher CA$ fair value estimate and raised price targets as a sign that recent regulatory developments are being reflected more fully in valuation assumptions.
DRUG
CA$85.20
Bright Minds Biosciences
7D
-11.4%
1Y
119.4%
KSI
CA$6.44
kneat.com
7D
18.8%
1Y
-2.7%
CURA
CA$13.84
Curaleaf Holdings
7D
-14.6%
1Y
323.2%
WELL
CA$4.55
WELL Health Technologies
7D
-6.0%
1Y
16.1%
GUD
CA$9.48
Knight Therapeutics
7D
10.1%
1Y
57.2%
Narrative Update • Jun 05

GUD: Latin American Approvals And Buybacks Will Support Future Bullish Repricing

Analysts have revised the fair value estimate for Knight Therapeutics from about CA$12.00 to roughly CA$11.65, reflecting updated assumptions on revenue growth, profit margins and a higher future P/E multiple. Recent Street research also includes higher CA$ price targets and renewed positive coverage.
ALGO
CA$0.31
Light AI
7D
31.9%
1Y
-7.5%
CSH.UN
CA$20.72
Chartwell Retirement Residences
7D
-3.4%
1Y
14.7%
Narrative Update • Jun 04

CSH.UN: Joint Venture And Palermo Acquisition Are Expected To Drive Further Upside

The analyst price target for Chartwell Retirement Residences has been raised by CA$1 to CA$25.95. Analysts point to recent updates in expected revenue growth, profit margins and P/E assumptions as key drivers of the change.
VRNO
CA$8.50
Verano Holdings
7D
4.3%
1Y
161.5%
Narrative Update • Jun 01

VRNO: Federal Reform Timing Will Drive Repricing As DEA Registrations Advance

Analysts now center their CA$5.00 price target for Verano Holdings on mixed research updates that balance broadly in-line Q4 sales and EBITDA with continued uncertainty around the timing of U.S. federal reform. Analyst Commentary Recent Street commentary centers on a CA$5.00 price target, with mixed signals around risk and reward.
HBFG
CA$1.65
Happy Belly Food Group
7D
7.8%
1Y
47.3%
AIRX
CA$2.90
Redwood AI
7D
-27.1%
1Y
n/a
AIDR
CA$0.71
Rocket Doctor AI
7D
26.8%
1Y
86.8%
EPRX
CA$8.45
Eupraxia Pharmaceuticals
7D
1.4%
1Y
57.9%
Analysis Article • May 20

We're Hopeful That Eupraxia Pharmaceuticals (TSE:EPRX) Will Use Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
EXE
CA$32.68
Extendicare
7D
-1.4%
1Y
130.5%
EBM
CA$0.95
Eastwood Bio-Medical Canada
7D
10.5%
1Y
183.6%